# US Negative Pressure Wound Therapy Market > US Negative Pressure Wound Therapy Market Research Report: Size, Share, Trend Analysis By Product Type (Devices, Accessories, Therapeutic Solutions), By Wound Type (Surgical Wounds, Chronic Wounds, Traumatic Wounds), By End Use (Hospitals, Home Healthcare, Ambulatory Surgical Centers) and By Applications (Burns, Ulcers, Post-Operative Wounds) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.77% - **2024:** $ 1,093.29 Million - **2025:** $ 1,145.44 Million - **2035:** $ 1,825.71 Million - **Key Players:** KCI Medical (US), Smith & Nephew (GB), Mölnlycke Health Care (SE), Convatec Group (GB), Acelity (US), Medtronic (IE), 3M (US), Hollister Incorporated (US) **Report ID:** MRFR/MED/14022-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-negative-pressure-wound-therapy-market-15549 --- ## Market Summary ## **US Negative Pressure Wound Therapy Market Overview** As per MRFR analysis, the US Negative Pressure Wound Therapy Market Size was estimated at 862.4 (USD Million) in 2023. The US Negative Pressure Wound Therapy Market Industry is expected to grow from 950(USD Million) in 2024 to 1,800 (USD Million) by 2035. The US Negative Pressure Wound Therapy Market CAGR (growth rate) is expected to be around 5.982% during the forecast period (2025 - 2035). ### **Key US Negative Pressure Wound Therapy Market Trends Highlighted** The US Negative Pressure Wound Therapy Market is experiencing significant growth due to several key market drivers. The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, drives demand for effective treatment solutions. Additionally, an aging population in the US is more susceptible to such wounds, increasing the need for advanced wound care products. Innovations in NPWT technology, including portable and more user-friendly devices, are also enhancing patient convenience and compliance. Moreover, the push from healthcare organizations and government initiatives towards quicker patient recovery times and reduced hospital stays fuels the adoption of negative pressure wound therapy. Opportunities in the US market are expanding as healthcare professionals recognize the benefits of NPWT for various types of wounds. Increased awareness among patients about the advantages of using advanced therapies is another area ripe for exploration. Furthermore, the integration of NPWT with telehealth services can provide better management and monitoring of patients’ wounds at home. The recent spikes in interest around at-home care solutions align well with the growing trend of personalized medicine, creating chances for manufacturers to introduce tailored products. In recent times, the trend towards hospital-at-home programs has accelerated, where patients receive care in their own environments, presenting new avenues for NPWT utilization. The growing focus on evidence-based practices in wound care is encouraging the adoption of clinical guidelines that recommend negative pressure therapy as a standard treatment protocol. These evolving trends highlight a shift towards more patient-centric care strategies within the US healthcare system, emphasizing efficient resource use while improving clinical outcomes for patients with complex wounds. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Negative Pressure Wound Therapy Market Drivers** ### **Growing Incidence of Chronic Wounds** The increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is a significant driver for the US Negative Pressure Wound Therapy Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 34.2 million Americans, or 10.5 percent of the population, have diabetes. This rising diabetic population contributes directly to an increase in diabetic foot wounds, which presents a significant healthcare challenge. Additionally, the International Diabetes Federation estimates that the cases of diabetes are expected to rise to 54 million by 2040 in the US, presenting further opportunities for growth in the negative pressure wound therapy segment. Established organizations like the American Diabetes Association are actively promoting awareness and management techniques, thus increasing the demand for advanced treatments, including negative pressure wound therapy, in the US. Therefore, this growing burden of chronic wounds is anticipated to drive product demand significantly in the coming years. ### **Technological Advancements in Negative Pressure Wound Therapy Devices** Continuous innovation and sophistication in negative pressure wound therapy devices are vital drivers for the US Negative Pressure Wound Therapy Market Industry. Companies like KCI Medical, a leader in advanced wound care, are consistently enhancing their product features, including portability, ease of use, and sophisticated sensor technologies that monitor the wound healing process more effectively. The FDA has reported an increase in the approval of new devices, enhancing patient outcomes and satisfaction. The integration of telemedicine and digital health technologies into wound care management is expected to provide patients with more effective and accessible treatments. As a result, the combination of these innovations will facilitate the growth of this market segment in the US. ### **Increasing Geriatric Population** The rising geriatric population in the United States is a key factor driving demand within the US Negative Pressure Wound Therapy Market Industry. According to the United States Census Bureau, the number of individuals aged 65 and older is projected to reach 94.7 million by 2060, nearly double from 52 million in 2018. This demographic is more susceptible to chronic wounds due to age-related factors such as mobility issues, skin fragility, and comorbidities like diabetes and vascular diseases. Organizations such as the American Geriatrics Society are emphasizing the need for better wound care management tailored to this age group. Consequently, the growing elderly population will likely lead to an increased demand for negative pressure wound therapy treatments to address chronic wounds effectively. ## **US Negative Pressure Wound Therapy Market Segment Insights** ### **Negative Pressure Wound Therapy Market Product Type Insights** The US Negative Pressure Wound Therapy Market showcases a multifaceted Product Type segmentation that encompasses Devices, Accessories, and Therapeutic Solutions, each contributing significantly to wound management processes. The Devices segment, known for its advanced technology, plays a vital role, facilitating effective suction that promotes healing by removing excess fluid and infectious materials from wounds. This segment is a cornerstone in treatment, providing a range of portable and easy-to-use options that cater to different patient needs. Accessories complement these Devices, including dressing materials that are designed to optimize the therapy's effectiveness. They help in maintaining a sealed environment and enhancing patient comfort, thereby improving adherence to treatment protocols. Meanwhile, Therapeutic Solutions focus on the pharmaceutical aspect of wound care, involving specialized treatments that work synergistically with the mechanical functions of Devices. This holistic approach drives the efficiency of negative pressure wound therapies, making them crucial in both hospital and home-care settings. The US market dynamics are influenced by growth drivers such as the increasing prevalence of chronic wounds due to conditions like diabetes and obesity, which are widespread within the population. Government initiatives and improved healthcare infrastructure emphasize the importance of wound care management, further propelling the adoption of various Product Types. Moreover, technological advancements continuously reshape the landscape, allowing for the introduction of more efficient Devices and accessories. However, these advancements also present challenges, including the need for training healthcare professionals to effectively utilize these technologies. The interplay between various segments signifies the importance of a comprehensive approach to wound healing that balances technology with supportive treatments, ultimately aligning with the trends observed in the broader US Negative Pressure Wound Therapy Market. As a result, this market is projected to exhibit significant growth and evolution, reflecting the increasing awareness and demand for effective wound management solutions among patients and healthcare providers alike. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Negative Pressure Wound Therapy Market Wound Type Insights** The US Negative Pressure Wound Therapy Market is focused on various wound types, each exhibiting distinct characteristics and demands. Surgical wounds constitute a major segment as they require effective management to promote healing post-operation and minimize complications, particularly in procedures with high infection rates. Chronic wounds, including diabetic and pressure ulcers, represent a growing concern due to the increasing prevalence of diabetes and an aging population, often necessitating advanced therapies for prolonged recovery times. Trauma-related wounds also play a significant role, given their urgency and complexity, which call for specialized treatment solutions to enhance healing processes and improve patient outcomes. Overall, understanding these wound types is essential in shaping the US Negative Pressure Wound Therapy Market segmentation, ultimately influencing product development, technology advancements, and clinical practices in the healthcare sector. As market growth unfolds, addressing the specific needs of each wound type not only improves care quality but also drives innovation in wound healing technologies. ### **Negative Pressure Wound Therapy Market End Use Insights** The 'US Negative Pressure Wound Therapy Market' has seen a marked trend towards specialization in its End Use segment, with critical applications in settings such as hospitals, home healthcare, and ambulatory surgical centers. Hospitals represent a vital avenue for Negative Pressure Wound Therapy, owing to their access to advanced technology and specialized staff that can address complex wound care needs. Home healthcare is gaining momentum as it allows for patient comfort and continuity of care, reflecting a growing preference among patients for receiving treatment in familiar environments. Ambulatory surgical centers increasingly leverage this technology for outpatient procedures, showcasing the adaptability of Negative Pressure Wound Therapy in various care settings. The consolidation of these settings significantly contributes to the efficacy and accessibility of wound management practices across the US, indicating a robust growth trajectory influenced by factors such as rising chronic diseases, an aging population, and advancements in wound care technologies. Furthermore, the increasing emphasis on reducing hospital stays and healthcare costs supports the rising demand in home healthcare and outpatient settings, making this market segment highly significant for patients and healthcare providers alike. ### **Negative Pressure Wound Therapy Market Application Insights** The Application segment of the US Negative Pressure Wound Therapy Market plays a crucial role in addressing various wound management needs, including Burns, Ulcers, and Post-Operative Wounds. Burns represent a significant challenge in the healthcare sector due to their complex healing process; thus, negative pressure wound therapy is utilized to enhance healing and minimize infection risks. Ulcers, particularly diabetic and pressure ulcers, are on the rise in the US, driven by the aging population and increasing diabetes cases, making this segment essential for improving patient outcomes and reducing hospital stays. Post-Operative Wounds also hold a major share in this market, as effective wound management is critical to preventing complications and ensuring a successful recovery post-surgery. Each of these applications contributes to the overall growth of the market, driven by advances in technology, increased awareness of wound care, and the ongoing need for effective therapeutic solutions in the healthcare industry. As healthcare providers continue to adopt innovative techniques and materials, the US Negative Pressure Wound Therapy Market remains poised for significant expansion within these specific applications, enhancing patient care and maintaining long-term health. ## **US Negative Pressure Wound Therapy Market Key Players and Competitive Insights** The US Negative Pressure Wound Therapy Market is characterized by its rapid growth and a dynamic competitive landscape driven by technological advancements, increasing incidences of chronic wounds, and rising healthcare expenditure. This market involves a diverse array of players including established corporations, emerging companies, and innovative startups, all of which contribute to enhanced product offerings and strategic market maneuvers. Competitive insights within this market highlight the significance of product differentiation, robust distribution channels, and the ability to leverage partnerships for broader market reach. Firms are increasingly focusing on research and development to deliver advanced solutions tailored to patient needs, thereby strengthening their market positions and expanding their share within this evolving sector. Smith and Nephew holds a prominent position in the US Negative Pressure Wound Therapy Market, distinguished by its commitment to innovation and high-quality product offerings. The company’s strengths lie in its established reputation for delivering reliable and effective therapeutic solutions, as well as its extensive distribution networks that enable widespread accessibility of its products. This strong market presence is supported by ongoing investments in research and development, aimed at introducing advanced NPWT systems that enhance patient outcomes. Smith and Nephew’s collaborative efforts with healthcare professionals and institutions further bolster its competitive edge, allowing for the incorporation of innovative feedback into product enhancements. Medela is another key player in the US Negative Pressure Wound Therapy Market, recognized for its focus on patient-centric solutions and high-quality medical technology. The company’s product portfolio encompasses a range of NPWT devices that target diverse patient needs, underscoring its capability to serve both acute and chronic wound cases effectively. Medela's strengths include a strong commitment to clinical support and education, which adds significant value to its product offerings by ensuring that healthcare providers are well-equipped to utilize its technologies. Recent strategic expansions, potentially marked by mergers and acquisitions, have augmented Medela's presence in the US market. This approach allows for greater integration of services and technologies, enhancing its competitive positioning and further solidifying its reputation within the realm of negative pressure wound therapy. ### **Key Companies in the US Negative Pressure Wound Therapy Market Include** ## **US Negative Pressure Wound Therapy Market Industry Developments** The US Negative Pressure Wound Therapy Market has recently seen significant developments that indicate a dynamic landscape. Companies like Smith and Nephew, ConvaTec, and Acelity have been actively innovating to improve their product offerings. For instance, Smith and Nephew launched an enhanced version of its negative pressure wound therapy device in June 2023, aiming to address chronic wounds more effectively. In August 2023, ConvaTec reported a growth in market valuation due to increased demand for advanced wound care solutions, particularly in the post-surgery recovery segment. Mergers and acquisitions are notable, with Medela acquiring a smaller competitor in the wound management space in September 2023 to expand its portfolio. Furthermore, B. Braun Medical and Cardinal Health have invested in Research and Development to create next-generation therapies, reflecting a focus on technological advancements in this market. Notably, the market valuation is experiencing growth fueled by changing patient demographics and rising incidences of chronic wounds, with the CDC reporting a steady increase in such cases over the past couple of years. Overall, these factors are driving the market forward, highlighting the potential for robust future growth in the US Negative Pressure Wound Therapy sector. ## **US Negative Pressure Wound Therapy Market Segmentation Insights** ### **Negative Pressure Wound Therapy Market Product Type Outlook** ### **Negative Pressure Wound Therapy Market Wound Type Outlook** ### **Negative Pressure Wound Therapy Market End Use Outlook** ### **Negative Pressure Wound Therapy Market Application Outlook** ## Market Drivers ### Rising Healthcare Expenditure The upward trajectory of healthcare expenditure in the US is significantly influencing the negative pressure-wound-therapy market. As healthcare budgets expand, hospitals and clinics are increasingly investing in advanced medical technologies, including NPWT systems. This trend is driven by the need to improve patient outcomes and reduce the overall cost of care associated with wound management. According to recent data, healthcare spending in the US is projected to reach $4.1 trillion by 2025, with a substantial portion allocated to innovative treatment modalities. Consequently, the negative pressure-wound-therapy market is likely to benefit from this financial commitment, as healthcare facilities prioritize the adoption of effective wound care solutions. ### Focus on Reducing Hospital Readmission Rates The emphasis on reducing hospital readmission rates is a significant driver for the negative pressure wound therapy market. Healthcare systems in the US are under pressure to improve patient outcomes and minimize costs associated with readmissions. NPWT has been shown to enhance healing rates and reduce complications, making it an attractive option for healthcare providers aiming to meet these goals. As hospitals and clinics adopt strategies to improve care continuity and patient management, the demand for effective wound care solutions like NPWT is expected to rise. This focus on quality care is likely to propel the negative pressure-wound-therapy market forward, as providers seek to implement best practices in wound management. ### Increasing Awareness of Wound Care Solutions The growing awareness surrounding effective wound care solutions is a pivotal driver for the negative pressure-wound-therapy market. Healthcare professionals and patients alike are becoming more informed about the benefits of advanced therapies, including negative pressure wound therapy (NPWT). This heightened awareness is likely to lead to increased adoption rates, as patients seek out effective treatments for chronic and complex wounds. In the US, educational initiatives and marketing campaigns by manufacturers are contributing to this trend, potentially resulting in a market growth rate of approximately 8% annually. As more healthcare providers recognize the efficacy of NPWT, the demand for these products is expected to rise, further solidifying their role in modern wound management. ### Aging Population and Associated Health Issues The demographic shift towards an aging population in the US is a critical driver for the negative pressure-wound-therapy market. Older adults are more susceptible to chronic wounds due to factors such as reduced mobility, comorbidities, and skin fragility. This demographic trend is expected to increase the demand for effective wound care solutions, including NPWT. By 2030, it is estimated that nearly 20% of the US population will be aged 65 and older, which could lead to a surge in chronic wound cases. As healthcare providers seek to address the needs of this growing population, the negative pressure-wound-therapy market is poised for expansion, as it offers a viable solution for managing complex wounds. ### Technological Innovations in Wound Management Technological innovations are reshaping the landscape of the negative pressure-wound-therapy market. Advances in NPWT devices, such as portable and user-friendly systems, are enhancing the accessibility and effectiveness of wound care. These innovations not only improve patient comfort but also facilitate at-home care, which is increasingly preferred by patients and healthcare providers. The introduction of smart NPWT devices, equipped with monitoring capabilities, is expected to further drive market growth. As these technologies become more prevalent, they are likely to attract investment and interest from healthcare facilities, thereby expanding the market's reach and potential. ## Future Outlook The [Negative Pressure Wound Therapy Market](https://www.marketresearchfuture.com/reports/negative-pressure-wound-therapy-market-6514) is projected to grow at a 4.77% CAGR from 2025 to 2035, driven by technological advancements and increasing chronic wound prevalence. **New opportunities:** - Development of portable NPWT devices for home care settings. - - Integration of AI for personalized wound management solutions. - Expansion of training programs for healthcare professionals on NPWT techniques. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Type: Devices (Largest) vs. Accessories (Fastest-Growing) In the US [negative pressure-wound-therapy market](https://www.marketresearchfuture.com/reports/negative-pressure-wound-therapy-market-6514), the segment distribution reveals that devices hold a significant portion of market share, dominating the category due to their critical role in wound management. Accessories also contribute to market dynamics, yet they are emerging as a vital player, indicating growing recognition and utilization among healthcare providers. The growth trends within this segment are driven by advancements in technology and an increasing awareness of the importance of effective wound care management. The rising incidence of chronic wounds and surgical site infections contributes to the demand for innovative and effective wound therapy solutions, propelling both the devices and accessories segments forward in this competitive landscape. Devices (Dominant) vs. Accessories (Emerging) Devices remain the dominant players in the US negative pressure-wound-therapy market, known for their essential functionality in managing complex wound care situations. These devices are clinically proven to enhance healing through consistent negative pressure, making them a staple in hospitals and clinics. On the other hand, accessories are gaining traction as they play a supportive role in enhancing the efficacy of the therapy. Accessories, including canisters and dressing materials, are increasingly recognized for their importance in the overall treatment regimen, capturing a growing market share as healthcare professionals focus on comprehensive patient care. ### By Wound Type: Chronic Wounds (Largest) vs. Surgical Wounds (Fastest-Growing) In the US negative pressure-wound-therapy market, the distribution of market share among the wound types reveals that chronic wounds are the largest segment, noticeably dominating the market. This is primarily due to the increasing prevalence of chronic conditions such as diabetes and obesity, which lead to a higher incidence of chronic wounds requiring extensive management and care. Surgical wounds, while smaller in market share, display remarkable growth trends that showcase their rising importance within the therapeutic landscape. The growth trends in this segment are fueled by advancements in wound care technologies and an increasing shift toward outpatient surgeries, resulting in more surgical interventions that generate post-operative care needs. The incorporation of negative pressure wound therapy in clinical practices is becoming standard, demonstrating its effectiveness in accelerating healing and reducing complications. As healthcare providers seek efficient solutions, surgical wounds are likely to emerge as one of the fastest-growing types in the landscape. Chronic Wounds (Dominant) vs. Surgical Wounds (Emerging) Chronic wounds represent the dominant force in the US negative pressure-wound-therapy market due to their long-lasting nature and the need for consistent care and innovative treatment solutions. Patients suffering from chronic conditions often experience complex wound management scenarios, requiring specialized therapies to promote healing. Conversely, surgical wounds are categorized as emerging, with a rapidly growing market presence fueled by the increase in outpatient surgeries. The application of negative pressure wound therapy in surgical settings is gaining momentum, as it significantly reduces healing time and the risk of infections. The competitive landscape is evolving, with manufacturers focusing on developing tailored solutions to address both chronic and surgical wound management, thereby enhancing patient outcomes and satisfaction. ### By End-use: Hospitals (Largest) vs. Home Healthcare (Fastest-Growing) The distribution of market share among the end-use segments indicates that hospitals currently hold the largest portion of the market, reflecting their extensive use of negative pressure wound therapy systems for complex wounds and post-surgical care. Home healthcare is rapidly gaining traction, driven by the rising preference for cost-effective and patient-centric treatment options, thus showing a significant growth in adoption among patients receiving care at home. In terms of growth trends, the US negative pressure-wound-therapy market is witnessing substantial advancements, primarily due to increasing incidences of chronic wounds and the growing geriatric population. The integration of advanced technologies in wound care products, alongside a shift towards home healthcare solutions, is propelling the rapid expansion of the market. As healthcare providers focus on reducing hospital stay durations and enhancing patient comfort, home healthcare emerges as a pivotal segment. Hospitals (Dominant) vs. Home Healthcare (Emerging) Hospitals remain the dominant end-use segment in the US negative pressure-wound-therapy market, attributed to their capacity to manage a wide range of complex wound cases and their access to advanced medical technologies. The robust infrastructure and trained personnel in hospitals enable efficient application of these therapies, fostering patient safety and recuperation. Conversely, the home healthcare segment is emerging due to a substantial shift in patient care preferences towards in-home treatment options. This segment is characterized by an increasing number of patients utilizing negative pressure wound therapy as part of their recovery at home, facilitated by advancements in portable devices and healthcare technologies. As a result, both segments exhibit unique characteristics that shape their market roles. ### By Application: Ulcers (Largest) vs. Burns (Fastest-Growing) In the US negative pressure-wound-therapy market, the primary application segments include ulcers, burns, and post-operative wounds, with ulcers holding the largest share due to their prevalence among healthcare settings. The significant occurrence of chronic wounds related to ulcers directly correlates with an increased demand for effective therapies, marking them as the dominant segment in terms of market share. This substantial market positioning reflects not only the prevalence of the conditions treated but also the established methodologies in wound care management. Conversely, burns are noted as the fastest-growing segment due to a rise in burn incidences, particularly in emergency settings. This growth is driven by advancements in wound care technology and increasing awareness of effective treatment options for burns. Overall, the landscape for applications in this market is evolving, with effective therapies being essential in addressing the needs associated with these varying wound types. Ulcers (Dominant) vs. Burns (Emerging) The ulcers segment represents a highly established area within the US negative pressure-wound-therapy market, largely due to the aging population and rising incidences of diabetic ulcers. This segment continues to benefit from long-term treatment protocols and a well-understood patient management process. In contrast, the burns segment is emerging rapidly, fueled by technological advancements and innovative therapies that cater specifically to burn patients. As healthcare providers become more aware of and equipped for effective burn management, this segment is poised for significant growth. Both segments, while distinct, play crucial roles in the market, catering to different patient needs and treatment modalities. ## Competitive Benchmarking The negative pressure-wound-therapy market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on enhancing patient outcomes. Key players such as KCI Medical (US), Smith & Nephew (GB), and Mölnlycke Health Care (SE) are actively pursuing strategies that emphasize technological advancements and market expansion. KCI Medical (US) has positioned itself as a leader through continuous product innovation, particularly in the development of advanced wound care solutions that integrate digital health technologies. Meanwhile, Smith & Nephew (GB) appears to be focusing on strategic acquisitions to bolster its product portfolio and enhance its market presence, thereby intensifying competition within the sector. Mölnlycke Health Care (SE) is also notable for its commitment to sustainability, which resonates with the growing demand for environmentally responsible healthcare solutions, further influencing the competitive dynamics of the market.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the market is moderately fragmented, with several key players exerting significant influence. This fragmentation allows for a diverse range of products and solutions, catering to various patient needs and preferences. The collective actions of these companies contribute to a dynamic environment where innovation and operational excellence are paramount. In October KCI Medical (US) announced the launch of a new digital platform designed to enhance patient engagement and streamline wound management processes. This strategic move is likely to position KCI Medical (US) at the forefront of digital transformation in wound care, potentially improving patient outcomes and operational efficiencies. Similarly, in September 2025, Smith & Nephew (GB) completed the acquisition of a smaller competitor specializing in advanced wound care technologies. This acquisition not only expands Smith & Nephew's product offerings but also strengthens its competitive edge in a rapidly evolving market.Moreover, in August 2025, Mölnlycke Health Care (SE) unveiled a new line of sustainable wound care products, aligning with its commitment to environmental stewardship. This initiative is expected to attract a growing segment of environmentally conscious healthcare providers and patients, thereby enhancing Mölnlycke's market position. In July Convatec Group (GB) launched a comprehensive training program for healthcare professionals focused on the effective use of negative pressure wound therapy. This program aims to improve clinical outcomes and foster loyalty among healthcare providers, indicating Convatec's strategic focus on education and support. As of November the competitive trends in the negative pressure-wound-therapy market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into wound management solutions. Strategic alliances among key players are shaping the landscape, facilitating knowledge sharing and resource optimization. Looking ahead, it is anticipated that competitive differentiation will evolve, with a shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This evolution underscores the importance of not only meeting clinical needs but also addressing broader societal expectations regarding sustainability and patient engagement. ## Recent News & Developments The US Negative Pressure Wound Therapy Market has recently seen significant developments that indicate a dynamic landscape. Companies like Smith and Nephew, ConvaTec, and Acelity have been actively innovating to improve their product offerings. For instance, Smith and Nephew launched an enhanced version of its negative pressure wound therapy device in June 2023, aiming to address chronic wounds more effectively. In August 2023, ConvaTec reported a growth in market valuation due to increased demand for advanced wound care solutions, particularly in the post-surgery recovery segment. Mergers and acquisitions are notable, with Medela acquiring a smaller competitor in the wound management space in September 2023 to expand its portfolio. Furthermore, B. Braun Medical and Cardinal Health have invested in Research and Development to create next-generation therapies, reflecting a focus on technological advancements in this market. Notably, the market valuation is experiencing growth fueled by changing patient demographics and rising incidences of chronic wounds, with the CDC reporting a steady increase in such cases over the past couple of years. Overall, these factors are driving the market forward, highlighting the potential for robust future growth in the US Negative Pressure Wound Therapy Market sector. ## Report Scope | MARKET SIZE 2024 | 1093.29(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1145.44(USD Million) | | MARKET SIZE 2035 | 1825.71(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.77% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | KCI Medical (US), Smith & Nephew (GB), Mölnlycke Health Care (SE), Convatec Group (GB), Acelity (US), Medtronic (IE), 3M (US), Hollister Incorporated (US) | | Segments Covered | Type, Wound Type, End-use, Application | | Key Market Opportunities | Integration of advanced materials and automation in negative pressure-wound-therapy devices enhances treatment efficacy and patient compliance. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the negative pressure-wound-therapy market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US negative pressure-wound-therapy market in 2024?** A: The market valuation was $1093.29 Million in 2024. **Q: What is the projected market valuation for the US negative pressure-wound-therapy market by 2035?** A: The projected valuation for 2035 is $1825.71 Million. **Q: What is the expected CAGR for the US negative pressure-wound-therapy market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 4.77%. **Q: Which companies are considered key players in the US negative pressure-wound-therapy market?** A: Key players include KCI Medical, Smith & Nephew, Mölnlycke Health Care, Convatec Group, Acelity, Medtronic, 3M, and Hollister Incorporated. **Q: What are the main segments of the US negative pressure-wound-therapy market?** A: The main segments include Type, Wound Type, End-use, and Application. **Q: What was the valuation of devices in the US negative pressure-wound-therapy market in 2024?** A: The valuation of devices was between $400.0 Million and $650.0 Million in 2024. **Q: How much did the accessories segment contribute to the market in 2024?** A: The accessories segment contributed between $300.0 Million and $500.0 Million in 2024. **Q: What is the projected valuation for chronic wounds in the US negative pressure-wound-therapy market by 2035?** A: The projected valuation for chronic wounds by 2035 is between $500.0 Million and $900.0 Million. **Q: What was the market size for hospitals in the US negative pressure-wound-therapy market in 2024?** A: The market size for hospitals was between $600.0 Million and $1000.0 Million in 2024. **Q: What is the expected growth trend for post-operative wounds in the US negative pressure-wound-therapy market?** A: The valuation for post-operative wounds is projected to be between $493.29 Million and $825.71 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-negative-pressure-wound-therapy-market-15549*